Skip to main content Scroll Top
Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
Most Viewed Posts
Clear Filters
Neuroprotective effect of a new photobiomodulation technique against Aβ25-35 peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer’s disease suggested
Neuroprotective effect of a new photobiomodulation technique against Aβ25-35 peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer’s disease suggested
2 February 2018
The RECOVERY study: first results of a pilot clinical trial to evaluate brain photobiomodulation in acute concussion in sportspeople
The RECOVERY study: first results of a pilot clinical trial to evaluate brain photobiomodulation in acute concussion in sportspeople
13 October 2023
Alzheimer’s disease: the promise of new Non-Invasive Brain Stimulation methods
Alzheimer’s disease: the promise of new Non-Invasive Brain Stimulation methods
5 March 2026
24 October 2023

Clinical Trials on Alzheimer’s Disease (CTAD CHINA)

Read the article

Jacques Touchon (MD, PhD), University of Montpellier and Guillaume Blivet (MPH), REGEnLIFE, France.

Share this article